Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

TEM vs NTRA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NTRA Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–1 Matrix Metrics)

NTRA Overall Winner 6-Pillar Tally: TEM 3 – 3 NTRA Matrix Metrics: TEM 1 – 7 NTRA

As of Nov 17, 2026, Natera, Inc. (NTRA) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TEM carries a Unified Composite Score of 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin), whereas NTRA carries 46.5/100 (HOLD) at $286.70 (N/M Forward P/E, -8.5% operating margin).

  • Technical & Structure Timing Caution: TEM is currently in a Breakdown options structure phase (RSI 40.3); meanwhile NTRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 27.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TEM vs NTRA
TEM NASDAQ
Tempus AI, Inc. Class A Common Stock
Services-Computer Programming, Data Processing, Etc.
$63.08
-2.59% 1D
Market Cap $13.1B
TTM Revenue $1.51B
Forward P/E N/M
Beta / 30D Vol 2.51β · 93% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 51.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 40.3 · SMA20: $73.18 · SMA50: $72.83
NTRA NASDAQ Head-to-Head Winner
Natera, Inc. Common Stock
Services-Medical Laboratories
$286.70
-0.62% 1D
Market Cap $46.3B
TTM Revenue $2.91B
Forward P/E N/M
Beta / 30D Vol 1.53β · 76% Vol
Unified Composite Score
46.5 / 100 HOLD
Tech 35.0 Fund 44.0 Flow 57.0 Mom 55.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 28
RSI-14: 27.6 · SMA20: $365.46 · SMA50: $378.11

6-Pillar Scorecard Institutional Category Breakdown (TEM 3 – 3 NTRA)

Columns: Metric · TEM · NTRA
1. Valuation Multiples TEM
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 9.2x 15.6x
2. Growth & Scale NTRA
Revenue Growth (YoY) +23.1% +34.1%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $1.51B $2.91B
Market Cap $13.1B $46.3B
3. Profitability & Quality NTRA
Gross Margin 64.5% 65.1%
Operating Margin -18.5% -8.5%
Net Profit Margin -12.5% -5.7%
Return on Equity (ROE) -37.5% -10.5%
4. Balance Sheet & Cash Flow NTRA
Cash Generation (TTM) -$151M $32M
Cash Flow Margin -10.0% 1.1%
Net Cash / Leverage $841M Net Debt (2.86x D/E) $858M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning TEM
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 99.3% (44th %ile) 57.7% (30th %ile)
Put/Call OI Skew 0.49x (Call-Skewed) 1.04x (Balanced)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat TEM
OpEx & R&D Intensity 83.0% of Rev ($1.25B) 73.6% of Rev ($2.14B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Ecosystem & Network-Effect Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Health Information Services Operator Diagnostics & Research Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TEM (1) vs NTRA (7)
Institutional Metric TEM NTRA Criterion Row Edge
Market Capitalization
Scale
$13.1B $46.3B Larger Scale NTRA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+23.1% +34.1% Higher Growth NTRA
Operating Margin (TTM)
Profitability
-18.5% -8.5% Higher Margin NTRA
Net Profit Margin
Profitability
-12.5% -5.7% Higher Margin NTRA
Return on Equity (ROE)
Capital Efficiency
-37.5% -10.5% Higher ROE NTRA
52-Week Range Position
Momentum
46% ($41–$89) 41% ($181–$437) Stronger Trend TEM
Beta / 30D Volatility
Risk Regime
2.51β · 93% Vol 1.53β · 76% Vol Lower Realized Risk NTRA
Unified Institutional Score
Composite Signal
43.5 / 100 (HOLD) 46.5 / 100 (HOLD) Higher Composite NTRA
Trailing 12M Revenue (USD)
Operating Scale
$1.51B $2.91B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
64.5% 65.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.2x EV/Rev N/M PEG · 15.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$151M ($841M Net Debt (2.86x D/E)) $32M ($858M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TEM +26.26 pp
TEM: -1.96% · NTRA: -28.22%
3M Horizon TEM +14.79 pp
TEM: +2.99% · NTRA: -11.8%
6M Horizon NTRA +7.7 pp
TEM: +38.55% · NTRA: +46.25%
1Y Horizon NTRA +48.24 pp
TEM: -7.89% · NTRA: +40.35%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period TEM Revenue NTRA Revenue TEM Op. Margin NTRA Op. Margin Margin Leader
FY2018 N/A $260M N/A -44.5% NTRA
FY2019 N/A $300M N/A -38.5% NTRA
FY2020 N/A $390M N/A -55.3% NTRA
FY2021 N/A $630M N/A -74.8% NTRA
FY2022 $320M $820M -82.8% -66.0% NTRA
FY2023 $530M $1.08B -36.9% -41.2% TEM
FY2024 $690M $1.70B -99.7% -13.1% NTRA
FY2025 $1.27B $2.31B -19.9% -13.4% NTRA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TEM BREAKDOWN
36d in phase · OBV DISTRIBUTION
Current IV 99.3%
IV Percentile 44th %ile
Put/Call OI Skew 0.49x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact TEM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NTRA CONSOLIDATION
71d in phase · OBV DISTRIBUTION
Current IV 57.7%
IV Percentile 30th %ile
Put/Call OI Skew 1.04x (Balanced)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact NTRA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $64.76 · IV 84.1%

TEM vs. NTRA: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of TEM ($6,476) vs. NTRA ($28,848) against risk-defined 5-day vertical and put-wall option structures.

TEM Spot $64.76 · IV 84.1%
TEM Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $65 / $75 Bull Call Spread

Buy 1x $65C · Sell 1x $75C · 32d

Net Entry $365 Debit
T+5d @ +5% Move +$69 (+19%)
Max Risk / Buffer $365 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $60 / $55 Bull Put Spread

Sell 1x $60P · Buy 1x $55P · 32d

Net Entry $160 Credit
Max Credit / Yield +$160 (+47.1% RoM)
Max Risk / Buffer -9.8% Cushion ($340 Mgn)
5d Edge & Liquidity 68% PoP · Liq A
Simulate 5-Day Payoff →
NTRA Spot $288.48 · IV 54.8%
NTRA Options Simulator →
5-DAY BULLISH SWING Liq C

Dec 18 $290 / $320 Bull Call Spread

Buy 1x $290C · Sell 1x $320C · 32d

Net Entry $1,280 Debit
T+5d @ +5% Move +$313 (+24%)
Max Risk / Buffer $1,280 Capped
5d Edge & Liquidity 0.7x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $270 / $250 Bull Put Spread

Sell 1x $270P · Buy 1x $250P · 32d

Net Entry $445 Credit
Max Credit / Yield +$445 (+28.6% RoM)
Max Risk / Buffer -7.9% Cushion ($1,555 Mgn)
5d Edge & Liquidity 71% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TEM Moat Profile Ecosystem & Network-Effect Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $13.1B market capitalization and -18.5% operating margin.
OpEx & R&D Reinvestment 83.0% of Rev ($1.25B)
90D Engineering Disclosures 0 Published · AI Drug Discovery
NTRA Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $46.3B market capitalization and -8.5% operating margin.
OpEx & R&D Reinvestment 73.6% of Rev ($2.14B)
90D Engineering Disclosures 0 Published

Investor FAQ TEM vs NTRA Key Questions & Quantitative Answers

As of Nov 17, 2026, Natera, Inc. (NTRA) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TEM carries a Unified Composite Score of 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin), whereas NTRA carries 46.5/100 (HOLD) at $286.70 (N/M Forward P/E, -8.5% operating margin). Technical & Structure Timing Caution: TEM is currently in a Breakdown options structure phase (RSI 40.3); meanwhile NTRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 27.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NTRA leads the Growth & Scale pillar: TEM posts +23.1% YoY revenue growth and +0.0% YoY earnings growth on $1.51B TTM revenue (64.5% gross margin, -18.5% operating margin), compared with NTRA at +34.1% YoY revenue growth and +0.0% YoY earnings growth on $2.91B TTM revenue (65.1% gross margin, -8.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), TEM cumulative revenue shifted +296.9% while NTRA shifted +788.5%. In operating R&D and SG&A reinvestment, TEM deploys 83.0% of Rev ($1.25B) (0 90-day corporate R&D disclosures) versus 73.6% of Rev ($2.14B) (0 disclosures) for NTRA.

TEM screens cheaper on headline valuation multiples. TEM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.2x EV/Revenue (-10.0% FCF margin), whereas NTRA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 15.6x EV/Revenue (1.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TEM (-37.5% ROE) versus NTRA (-10.5% ROE) capital efficiency.

In options market volatility and institutional positioning, TEM carries 99.3% implied volatility (44th %ile, Balanced (25th–60th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.51β · 93% Vol realized risk). By comparison, NTRA carries 57.7% implied volatility (30th %ile, Balanced (25th–60th %ile)), a 1.04x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.53β · 76% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.